EYLEA Is Estimated To Witness High Growth Owing To Rising Prevalence Of Diabetic Retinopathy And Wet Age-Related Macular Degeneration

 EYLEA, also known as aflibercept, is a vascular endothelial growth factor (VEGF) inhibitor used in the treatment of several eye diseases. It is used to treat wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), diabetic retinopathy (DR) and macular edema following retinal vein occlusion (RVO). EYLEA is administered via intravitreal injections directly into the eye.

The global EYLEA drug market was valued at US$ 8.79 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023-2030, as highlighted in a new report published by CoherentMI.

Market Dynamics:

The global EYLEA drug market is witnessing high growth owing to the rising prevalence of diabetic retinopathy and wet age-related macular degeneration. Diabetic retinopathy is a common complication of diabetes and a leading cause of vision loss globally. According to the International Diabetes Federation, nearly 237 million people worldwide had diabetes retinopathy in 2019. The rising diabetes burden globally is expected to increase the cases of diabetic retinopathy, thereby driving the demand for EYLEA for its treatment. Similarly, wet AMD is the advanced form of age-related macular degeneration which can cause rapid and severe vision loss if left untreated. The growing geriatric population prone to age-related eye diseases also contributes to the growth of the EYLEA drug market.

SWOT Analysis

Strength: EYLEA drug is an effective treatment for wet age-related macular degeneration and diabetic macular edema. It blocks VEGF activity which helps control abnormal blood vessel growth and leakage. EYLEA has also demonstrated good safety profile with minimal injection burden compared to other therapies. It has been shown to improve or maintain vision in patients for over 4 years with repeat injections.

Weakness: EYLEA has a high treatment cost as it needs repeat dosing every 8-12 weeks which can be a long term financial burden for patients. Some patients may also experience severe vision loss if treatment is discontinued.

Opportunity: The aging global population dealing with eye diseases like age-related macular degeneration and diabetic eye problems provides growth opportunities. Further approval for new indications like myopic choroidal neovascularization expands the addressable market.

Threats: Entry of biosimilar versions once patents expire pose pricing and competitive threats. Future innovation in drug delivery methods like port delivery systems can disrupt the market. Regulatory delays or setbacks during clinical trials also impact market presence.

Key Takeaways

The Global EYLEA Drug Market Size is expected to witness high growth driven by rising prevalence of retinal disorders in an aging population. EYLEA being the leading therapy approved for wet AMD and DME has established strong market presence.

The global EYLEA drug market was valued at US$ 8.79 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030.

The United States accounts for the largest share currently due to favorable reimbursement policies and consumer awareness. However, Asia Pacific region is expected to see fastest growth owing to rising incidence of diabetes and growing medical expenses in countries like China, India and South Korea. Favorable healthcare reforms, growing senior population and increasing economic burden of visual impairment are contributing factors. Government initiatives to expand insurance coverage and awareness programs can further stimulate the market.

Key Players related content comprises
Key players operating in the Global EYLEA Drug Market are Bayer, Regeneron Pharmaceuticals, Coherus BioSciences, Inc., and Klinge Biopharma. Bayer and Regeneron Pharmaceuticals currently lead the market and are involved in ongoing trials to expand EYLEA's label into additional eye disorders. Coherus Biosciences is working on a biosimilar version while Klinge Biopharma focuses on novel sustained-release drug delivery technologies.

Reasons to Purchase Global EYLEA Drug Market Report:

1. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

2. Develop/modify business expansion plans by using substantial growth offerings in developed and emerging markets.

3. Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Global EYLEA Drug Market .

FAQ’s

Q.1 What will the market development pace of the Global EYLEA Drug Market?

Q.2 What are the sales, revenue, and price analysis of the top players of the Global EYLEA Drug Market?

Q.3 What are the market opportunities and threats faced by the vendors in the Global EYLEA Drug Market?

Explorer more information on this topic, Please visit @ 
https://www.pressreleasebulletin.com/global-eylea-drug-market-demand-and-forecast-analysis/

Comments

Post a Comment

Popular posts from this blog

U.S. Artificial Sweeteners Market Is Estimated To Witness High Growth Owing To Increasing Low-Calorie Snack Products Consumption

  Artificial sweeteners are commonly used as sugar substitutes in beverages, dairy products, cereal, baked goods, confectionery, etc. They are widely used to reduce the calories and carbohydrate content in food and drinks without compromising the sweetness. Increasing health consciousness among consumers has significantly boosted the demand for low-calorie and sugar-free products. Growing adoption of healthy snacking and on-the-go consumption trend in the U.S. has accelerated the demand for low-calorie snack products incorporated with artificial sweeteners. The global U.S. artificial sweeteners market was valued at US$ 2.66 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by CoherentMI. Market Dynamics: Low-calorie food products incorporated with artificial sweeteners have witnessed substantial growth in the U.S. over the past few years, attributed to rising health awareness among consumers. Accordi...
Read more

India Fast Fashion Market Primed to Witness High Growth Owing To Increased Millennial Population

  Fast fashion refers to clothing designs that moves from the runway to retail stores quickly and at low prices. Fast fashion clothing collections are based on the latest fashion trends seen on runways and red carpets. Fast fashion products include tops, bottoms, dresses, etc. manufactured using cheaper materials and manufacturing techniques to reduce costs. Fast fashion has gained immense popularity among the younger generation and millennial population in India who prefer trendy yet affordable outfits. The availability of fast fashion products at affordable prices through both offline and online retail channels has significantly boosted their adoption in the country. The India fast fashion market is estimated to be valued at US$ 9.90 billion in 2023 and is expected to exhibit a CAGR of 16.5% over the forecast period 2023 to 2030, as highlighted in a new report published by CoherentMI. Market Dynamics: One of the major drivers for the growth of the India fast fashion market...
Read more

Middle East And Central Asia Creator Economy Market Estimated To Witness High Growth Owing To Increasing Social Media Usage

  Market Overview: The Middle East And Central Asia Creator Economy Market refers to a new economy that is emerging around the monetization of creative content online. It includes content creators such as YouTubers, Instagram influencers, podcasters, bloggers and more. The growing usage of social media platforms has enabled millions of individuals to create and share content online and generate an income from brands, sponsors, subscriptions and advertisement revenue sharing programs. The Middle East And Central Asia Creator Economy Market was valued at US$ 229.5 million in 2023 and is expected to exhibit a CAGR of 21.3% over the forecast period 2023-2030, as highlighted in a new report published by CoherentMI. Market Dynamics: The increasing usage of social media platforms in the region is expected to drive the growth of the Middle East And Central Asia Creator Economy Market. According to recent statistics, the active social media user penetration in the region stands at aroun...
Read more